CRCA vs. USD
CRCA (ProShares Ultra CRCL) and USD (ProShares Ultra Semiconductors) are both Leveraged Equities funds from ProShares. CRCA is actively managed, while USD is passively managed. At a 0.31 correlation, their price movements are largely independent. Both charge a 0.95% expense ratio.
Performance
CRCA vs. USD - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CRCA achieves a -25.12% return, which is significantly lower than USD's 103.32% return.
CRCA
- 1D
- 0.33%
- 1M
- -42.95%
- YTD
- -25.12%
- 6M
- -41.42%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
USD
- 1D
- -4.99%
- 1M
- 31.62%
- YTD
- 103.32%
- 6M
- 97.79%
- 1Y
- 250.81%
- 3Y*
- 125.78%
- 5Y*
- 67.80%
- 10Y*
- 61.24%
CRCA vs. USD - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
CRCA ProShares Ultra CRCL | -25.12% | -81.81% |
USD ProShares Ultra Semiconductors | 103.32% | 19.19% |
Correlation
The correlation between CRCA and USD is 0.31, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Aug 8, 2025 | 0.31 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CRCA vs. USD — Risk / Return Rank
CRCA
USD
CRCA vs. USD - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and ProShares Ultra Semiconductors (USD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| CRCA | USD | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 4.12 | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.89 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.89 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.47 | 0.49 | -0.95 |
Drawdowns
CRCA vs. USD - Drawdown Comparison
The maximum CRCA drawdown since its inception was -94.02%, which is greater than USD's maximum drawdown of -88.63%. Use the drawdown chart below to compare losses from any high point for CRCA and USD.
Loading charts...
Drawdown Indicators
| CRCA | USD | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -94.02% | -88.63% | -5.39% |
Max Drawdown (1Y)Largest decline over 1 year | — | -31.80% | — |
Max Drawdown (3Y)Largest decline over 3 years | — | -64.46% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -77.85% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -77.85% | — |
Current DrawdownCurrent decline from peak | -87.94% | -6.07% | -81.87% |
Average DrawdownAverage peak-to-trough decline | -69.35% | -32.35% | -37.00% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 10.98% | — |
Volatility
CRCA vs. USD - Volatility Comparison
Loading charts...
Volatility by Period
| CRCA | USD | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 21.29% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 46.74% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 196.32% | 61.28% | +135.04% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 196.32% | 76.56% | +119.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 196.32% | 69.24% | +127.08% |
CRCA vs. USD - Expense Ratio Comparison
Both CRCA and USD have an expense ratio of 0.95%.
Dividends
CRCA vs. USD - Dividend Comparison
CRCA's dividend yield for the trailing twelve months is around 2.31%, more than USD's 0.23% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CRCA ProShares Ultra CRCL | 2.31% | 1.06% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
USD ProShares Ultra Semiconductors | 0.23% | 0.39% | 0.10% | 0.05% | 0.30% | 0.00% | 0.14% | 0.72% | 0.93% | 0.32% | 0.46% | 0.39% |
Frequently Asked Questions
CRCA and USD have a correlation of 0.31, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Both ETFs have the same 0.95% expense ratio. The better choice depends on whether you care most about return, fees, risk, or income.
CRCA and USD have the same expense ratio: 0.95% per year.
CRCA has the higher dividend yield at 2.31%, compared with 0.23% for USD.
Find the right allocation for CRCA and USD
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer